Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study

January 2011
BMC Public Health;2011, Vol. 11 Issue 1, p646
Academic Journal
The article offers information on a study conducted by the authors related to economic burden of stroke depending upon age on onset in South Korea. It states that transition probabilities for fatal and non-fatal recurrent stroke by age and gender were derived from the Korean Health Insurance Review and Assessment Services. Lifetime costs of stroke were estimated to be 81.9 and 16.4 million Korean won for men who suffered first stroke at the age of 55 and 65 years respectively in 2007.


Related Articles

  • Medizinisch-technischer Fortschritt und altersspezifische Gesundheitsausgaben. Ried, Walter // Jahrbucher fur Nationalokonomie & Statistik;Nov2007, Vol. 227 Issue 5/6, p636 

    This paper investigates the impact of population aging, driven by medical progress, upon age-specific expenditure on health care. In a model set up in discrete time, individuals at each age may catch a lethal disease which, upon receiving appropriate medical treatment, nevertheless involves a...

  • The impact of changes in intensive care organization on patient outcome and costeffectiveness--a narrative review. van der Sluijs, Alexander F.; van Slobbe-Bijlsma, Eline R.; Chick, Stephen E.; Vroom, Margreeth B.; Dongelmans, Dave A.; Vlaar, Alexander P. J. // Journal of Intensive Care;1/25/2017, Vol. 5, p1 

    The mortality rate of critically ill patients is high and the cost of the intensive (ICU) department is among the highest within the health-care industry. The cost will continue to increase because of the aging population in the western world. In the present review, we will discuss the impact of...

  • Cost of epilepsy variable in Italy.  // PharmacoEconomics & Outcomes News;4/10/2004, Issue 450, p9 

    Discusses research being done on the association of medical costs with epilepsy in Italy. Reference to a study by E. Beghi and colleagues, published in the February 2004 issue of "Epilepsia" journal; Categories of patients in terms of prognosis; Findings of the study.

  • Brain disorders burden the UK economy.  // PharmacoEconomics & Outcomes News;8/1/2013, Issue 684, p5 

    An abstract of the article "The size, burden and cost of disorders of the brain in the UK," by N. A. Fineberg and colleagues is presented.

  • Advances in cerebrovascular disease research in the last year. López, Mirta; Dávalos, Antoni // Journal of Neurology;Jan2011, Vol. 258 Issue 1, p168 

    The following review summarizes the progress in cerebrovascular disease research published in the Journal of Neurology in the last year.

  • Diffusion tensor imaging: implications for brain disease. Singh-Curry, Victoria; Roberts, Richard E.; Husain, Masud // Journal of Neurology, Neurosurgery & Psychiatry;May2008, Vol. 79 Issue 5, p490 

    The author discusses the implications of diffusion tensor imaging (DTI) on brain disease. He refers to a study by Urbansky and colleagues where DTI was used to assess the integrity of white matter tracts connecting anterior and posterior regions of the right hemisphere. He claims the finding is...

  • The burden of disease in Korea. In-Hwan Oh; Seok-Jun Yoon; Eun-Jung Kim // Journal of the Korean Medical Association / Taehan Uisa Hyophoe ;Jun2011, Vol. 54 Issue 6, p646 

    The disability adjusted life year (DALY), a single indicator of the burden of disease, is widely used to measure the burden of diseases, injuries, and risk factors. In this study, we review the relative sizes of the burden of disease worldwide and the characteristics of the burden of disease of...

  • THE ALLOCATION OF SCARCE RESOURCES: SOCIAL HOUSING. Furnham, Adrian; Mcclelland, Alastair // Social Behavior & Personality: An International Journal;2004, Vol. 32 Issue 1, p45 

    Previous studies on the allocation of scarce medical resources have shown that certain patient variables (e.g. sex. age, number of dependants) significantly affect lay participants' rank ordering of them for costly treatment. This study replicates the methodology of these studies (Furnham,...

  • Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries: France, Italy, Germany and the UK. Lafuma, Antoine; Brézin, Antoine; Lopatriello, Stefania; Hieke, Klaus; Hutchinson, Julia; Mimaud, Viviane; Berdeaux, Gilles // PharmacoEconomics;2006, Vol. 24 Issue 2, p193 

    Introduction: Visual impairment is a severe disability that puts a heavy burden on individuals, families and society. In developed countries, the two major diseases leading to irreversible visual impairment are glaucoma and age-related macular degeneration. Their prevalence will increase...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics